Dovato (dolutegravir/lamivudine) is a prescription drug that’s used to treat HIV in adults and some children. Dovato’s cost may depend on factors such as the ...
Seeking Alpha: ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain
In largest head-to-head randomized clinical trial evaluating the two medicines, Dovato (DTG/3TC) met the primary endpoint, demonstrating sustained non-inferior efficacy versus Biktarvy (BIC/FTC/TAF) ...
ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain
Dovato (dolutegravir/lamivudine) is a prescription oral tablet used for HIV in certain situations. Dovato can cause side effects that range from mild to serious ...
Monthly Prescribing Reference: Dovato Approval Expanded to Include Adolescents Living With HIV
Dovato is a complete treatment for HIV in certain adults and children, taken as 1 tablet per day. Dovato’s side effects can range from mild issues like headache and nausea to more serious ones, such ...
Business Wire: ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of ...
ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of ...
FiercePharma: GSK's Dovato matches Gilead's HIV juggernaut Biktarvy with less weight gain in Spanish trial
In HIV treatment, Gilead Sciences’ popular Biktarvy serves as a benchmark for newer drugs to overcome. In a new head-to-head study, GSK’s two-drug regimen Dovato showed comparable antiviral efficacy ...